Yungjin Pharm Co Ltd
KRX:003520

Watchlist Manager
Yungjin Pharm Co Ltd Logo
Yungjin Pharm Co Ltd
KRX:003520
Watchlist
Price: 1 966 KRW -2.91% Market Closed
Market Cap: 359.6B KRW

Wall Street
Price Targets

Price Targets Summary
Yungjin Pharm Co Ltd

There are no price targets for Yungjin Pharm Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Yungjin Pharm Co Ltd Competitors:
Price Targets
216080
Jetema Co Ltd
37% Upside
600750
Jiang Zhong Pharmaceutical Co Ltd
25% Upside
600267
Zhejiang Hisun Pharmaceutical Co Ltd
30% Downside
600521
Zhejiang Huahai Pharmaceutical Co Ltd
21% Upside
MVP
Medical Developments International Ltd
58% Upside
600276
Jiangsu Hengrui Pharmaceuticals Co Ltd
29% Upside

Revenue
Forecast

Revenue Estimate
Yungjin Pharm Co Ltd

For the last 13 years the compound annual growth rate for Yungjin Pharm Co Ltd's revenue is 6%. The projected CAGR for the next 9 years is -4%.

6%
Past Growth
-4%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Yungjin Pharm Co Ltd

For the last 13 years the compound annual growth rate for Yungjin Pharm Co Ltd's operating income is 7%. The projected CAGR for the next 9 years is -1%.

7%
Past Growth
-1%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Yungjin Pharm Co Ltd

For the last 13 years the compound annual growth rate for Yungjin Pharm Co Ltd's net income is -6%. The projected CAGR for the next 9 years is 20%.

-6%
Past Growth
20%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Yungjin Pharm Co Ltd's stock price target?
Not Available

Yungjin Pharm Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Yungjin Pharm Co Ltd's Revenue forecast?
Projected CAGR
-4%

For the last 13 years the compound annual growth rate for Yungjin Pharm Co Ltd's revenue is 6%. The projected CAGR for the next 9 years is -4%.

What is Yungjin Pharm Co Ltd's Operating Income forecast?
Projected CAGR
-1%

For the last 13 years the compound annual growth rate for Yungjin Pharm Co Ltd's operating income is 7%. The projected CAGR for the next 9 years is -1%.

What is Yungjin Pharm Co Ltd's Net Income forecast?
Projected CAGR
20%

For the last 13 years the compound annual growth rate for Yungjin Pharm Co Ltd's net income is -6%. The projected CAGR for the next 9 years is 20%.

Back to Top